Singer Nicholas Jason 4
4 · Brooklyn ImmunoTherapeutics, Inc. · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Singer Nicholas Jason
Director
Transactions
- Award
Stock Option (right to buy)
2022-08-01+146,100→ 146,100 totalExercise: $0.49Exp: 2032-08-01→ Common Stock, par value $0.005 per share (146,100 underlying) - Award
Stock Option (right to buy)
2022-08-01+165,800→ 165,800 totalExercise: $0.49Exp: 2032-08-01→ Common Stock, par value $0.005 per share (165,800 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable over one year (subject to continued service), with 25% of the shares vesting every three months from the grant date.
- [F2]The stock option vests and becomes exercisable over two years (subject to continued service), with 1/3 of the shares vesting on the grant date and the remaining shares vesting in 24 substantially equal monthly installments thereafter.